• TRIAL ALERTS

• HEALTH NEWS

• RSS FEEDS

• ABOUT TRIALS

• LINK TO US

Results from Clinical Connection:

(Hide Results...)

Your search returned no results. Get alerts when studies become available.

Results from other databases:

(Hide Results...)

Your search returned 150 studies: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Auburn, Washington Integrative Oncology Outcomes Study in Breast Cancer Conditions: Breast Cancer Location: Bellevue, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Bellevue, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Federal Way, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Bellevue, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Federal Way, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Bellevue, Washington Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Conditions: Breast Cancer Location: Federal Way, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Bellevue, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Federal Way, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Kirkland, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Kirkland, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Issaquah, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Kirkland, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Issaquah, Washington Integrative Oncology Outcomes Study in Breast Cancer Conditions: Breast Cancer Location: Kenmore, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Issaquah, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Edmonds, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Edmonds, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Issaquah, Washington A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer Conditions: Breast Cancer Location: Edmonds, Washington Radiologic Evaluation and Breast Density (READ) Conditions: Breast Cancer Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Edmonds, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Edmonds, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Issaquah, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Kirkland, Washington Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Conditions: Breast Cancer Location: Seattle, Washington Integrative Oncology Outcomes Study in Breast Cancer Conditions: Breast Cancer Location: Renton, Washington Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer Conditions: Breast Cancer - Cancer Survivor - Hot Flashes Location: Seattle, Washington Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer Conditions: Breast Cancer - Cancer Survivor - Hot Flashes Location: Seattle, Washington The BEACON Study (Breast Cancer Outcomes With NKTR-102) Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Conditions: Breast Neoplasms - Breast Cancer - Breast Tumors Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer Conditions: Breast Cancer - Breast Cancer Surgery Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer Conditions: Breast Cancer - Cancer Survivor - Hot Flashes Location: Seattle, Washington Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Conditions: HER2 Negative Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Seattle, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Sequim, Washington Vaccine Therapy in Treating Patients With Stage IV Breast Cancer Conditions: HER2-positive Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer Location: Seattle, Washington A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Wo Conditions: Breast Cancer Location: Seattle, Washington Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer Conditions: Breast Cancer - Depression - Long-term Effects of Cancer Treatment - Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Bremerton, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Burien, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Poulsbo, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Puyallup, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Seattle, Washington Study of Radiation Exposure and Bilateral Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Multi-Media Imagery Program for Breast Cancer Patients (Phase II) Conditions: Breast Cancer Location: Seattle, Washington I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Conditions: Breast Neoplasms - Breast Cancer - Breast Tumors Location: Seattle, Washington Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) Conditions: Breast Cancer Location: Seattle, Washington Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer - Triple- Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Bremerton, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Burien, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Poulsbo, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer) Conditions: Breast Cancer - Ovarian Cancer Location: Seattle, Washington Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors Conditions: Breast Cancer Location: Seattle, Washington Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer Conditions: Breast Cancer - Breast Cancer Surgery Location: Seattle, Washington Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Conditions: Breast Cancer Location: Bremerton, Washington Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Puyallup, Washington Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Patients With Stage II-IV HER2-Positive Breast Cancer Conditions: HER2-positive Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer Location: Seattle, Washington Integrative Oncology Outcomes Study in Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer Conditions: ER Positive, Her2 Negative Breast Cancer Patients - Triple Negative Breast Cancer Patients Location: Seattle, Washington The BEACON Study (Breast Cancer Outcomes With NKTR-102) Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Bremerton, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Burien, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Poulsbo, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Bremerton, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Burien, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Poulsbo, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Puyallup, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer Location: Seattle, Washington Psychoeducation for Spouses of Women With Breast Cancer Conditions: Breast Cancer Location: Seattle, Washington Vaccine Therapy in Treating Patients With Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer Location: Tacoma, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Centralia, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Olympia, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Tacoma, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Tacoma, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Tacoma, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Tacoma, Washington S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific Location: Tacoma, Washington High-dose Methotrexate and Liposomal Cytarabine in Treating Patients With CNS Metastases From Breast Cancer Conditions: Central Nervous System Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Stage IV Breast Cancer - Tumors Metastatic to Brain Location: Seattle, Washington Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) Conditions: Breast Cancer Location: Tacoma, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Tacoma, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Bremerton, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Burien, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Poulsbo, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Seattle, Washington Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can Location: Sequim, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Centralia, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Olympia, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Tacoma, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Tacoma, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Tacoma, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Tacoma, Washington Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders Location: Tacoma, Washington A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer Conditions: Breast Cancer Location: Everett, California Integrative Oncology Outcomes Study in Breast Cancer Conditions: Breast Cancer Location: Lacey, Washington Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Conditions: HER2 Negative Breast Cancer Location: Tacoma, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Centralia, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Olympia, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Conditions: Breast Cancer Location: Tacoma, Washington A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) And Vinorelbine in First Line in Patients With Metastatic or Locally Advanced HER2-P Conditions: Breast Cancer Location: Seattle, Washington A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) And Vinorelbine in First Line in Patients With Metastatic or Locally Advanced HER2-P Conditions: Breast Cancer Location: Seattle, Washington Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Plac Conditions: Metastatic Breast Cancer Location: Tacoma, Washington Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer Conditions: HER2-positive Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer Location: Seattle, Washington

Didn't find what you were looking for? Try these alternatives: